Background and purpose: Acid-sensing ion channels (ASICs) are neuronal proton sensors emerging as potential therapeutic targets in pain of the orofacial region. Amiloride, a non‐specific ASIC blocker, has been shown to exert beneficial effects in animal models of migraine and in patients. We explored the involvement of the ASIC1‐subtype in...
-
2018 (v1)Journal articleUploaded on: December 4, 2022
-
July 12, 2023 (v1)Journal article
Migraine constitutes the world's second-leading cause of disability. Triptans, as serotonin 5-HT1B/1D receptor agonists, remain the first-line treatment, despite discouraged use in individuals at high cardiovascular risk. Lasmiditan, a selective lipophilic 5-HT1F agonist without vasoconstrictive effects, is an emerging option. We aimed to...
Uploaded on: September 5, 2023 -
April 1, 2018 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
October 2017 (v1)Journal article
International audience
Uploaded on: March 26, 2023